Log in

AVITA Therapeutics, Inc. (AVH.AX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range
MA: A$0.50
52-Week Range N/A
Volume27.28 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Avita Medical Limited operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices



Sales & Book Value

Annual Sales$16.07 million
Book ValueA$0.61 per share



Next Earnings DateN/A

Receive AVH News and Ratings via Email

Sign-up to receive the latest news and ratings for AVH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

AVITA Therapeutics, Inc. (AVH.AX) (ASX:AVH) Frequently Asked Questions

What stocks does MarketBeat like better than AVITA Therapeutics, Inc. (AVH.AX)?

Wall Street analysts have given AVITA Therapeutics, Inc. (AVH.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AVITA Therapeutics, Inc. (AVH.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were AVITA Therapeutics, Inc. (AVH.AX)'s earnings last quarter?

AVITA Therapeutics, Inc. (AVH.AX) (ASX:AVH) announced its earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.01) by $0.01.
View AVITA Therapeutics, Inc. (AVH.AX)'s earnings history

Who are some of AVITA Therapeutics, Inc. (AVH.AX)'s key competitors?

What other stocks do shareholders of AVITA Therapeutics, Inc. (AVH.AX) own?

Who are AVITA Therapeutics, Inc. (AVH.AX)'s key executives?

AVITA Therapeutics, Inc. (AVH.AX)'s management team includes the following people:
  • Dr. Michael S. Perry D.V.M., DVM, Ph.D., FACVPT, CEO & Exec. Director (Age 61, Pay $1.88M)
  • Mr. David John McIntyre C.P.A., L.L.B., M.B.A., MBA, LL.B., CPA, B.Econs(A, Chief Financial Officer (Age 50, Pay $326.8k)
  • Mr. Andrew Quick, Chief Technology Officer (Age 49, Pay $454.27k)
  • Ms. Donna Shiroma, Gen. Counsel & Sec. (Age 57, Pay $452.18k)
  • Ms. Erin Liberto, Chief Commercial Officer (Age 45, Pay $475.54k)
  • Mr. David Fencil, VP of Global Operations
  • Ms. Debbie Garner, VP of Global Marketing

What is AVITA Therapeutics, Inc. (AVH.AX)'s stock symbol?

AVITA Therapeutics, Inc. (AVH.AX) trades on the ASX under the ticker symbol "AVH."

How big of a company is AVITA Therapeutics, Inc. (AVH.AX)?

AVITA Therapeutics, Inc. (AVH.AX) has a market capitalization of $0.00 and generates $16.07 million in revenue each year. AVITA Therapeutics, Inc. (AVH.AX) employs 98 workers across the globe.

What is AVITA Therapeutics, Inc. (AVH.AX)'s official website?

The official website for AVITA Therapeutics, Inc. (AVH.AX) is www.avitamedical.com.

How can I contact AVITA Therapeutics, Inc. (AVH.AX)?

The company can be reached via phone at 661-367-9170.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.